Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia.

MLA

Witjes, W. P., et al. “Urodynamic and Clinical Effects of Terazosin Therapy in Patients with Symptomatic Benign Prostatic Hyperplasia.” The Journal of Urology, vol. 155, no. 4, Apr. 1996, pp. 1317–23. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8632523&authtype=sso&custid=ns315887.

APA

Witjes, W. P., Rosier, F. W., de Wildt, M. J., van Iersel, M. P., Debruyne, F. M., & de La Rosette, J. J. (1996). Urodynamic and clinical effects of terazosin therapy in patients with symptomatic benign prostatic hyperplasia. The Journal of Urology, 155(4), 1317–1323.

Chicago

Witjes, W P, F W Rosier, M J de Wildt, M P van Iersel, F M Debruyne, and J J de La Rosette. 1996. “Urodynamic and Clinical Effects of Terazosin Therapy in Patients with Symptomatic Benign Prostatic Hyperplasia.” The Journal of Urology 155 (4): 1317–23. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=8632523&authtype=sso&custid=ns315887.